跳至主要内容
临床试验/JPRN-UMIN000023463
JPRN-UMIN000023463已完成未知

Effect of alogliptin/pioglitazone on endothelial function and Visceral fat of Type 2Diabetes - Effect of alogliptin/pioglitazone on endothelial function and Visceral fat of Type 2Diabetes

Dokkyo medical university hospital0 个研究点目标入组 30 人开始时间: 2016年8月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with hypersensitivity to the components of alogliptin or sulfonylurea. 2)Patients with severe ketosis ,diabetic coma or pre coma. 3)Patients with severe infection,before and after surgery,severe trauma. 4)Patient with advanced renal dysfunction(eGFR<30) or patient on dialysis. 5)Patients with severe liver dysfunction. 6)Patients with pregnancy or possibility. 7)Patients whom physician in charge considered inappropriate for study.

研究者

相似试验